The effects of benzene and the metabolites phenol and catechol on c-Myb and Pim-1 signaling in HD3 cells

Toxicology and Applied Pharmacology

Volumn 201, Issue 2, 2004, Pages 194-201

  Wan, Joanne ^a   Winn, Louise M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Benzene; c Myb; Catechol; Phenol; Pim 1; Reactive oxygen species; ROS

Indexed keywords

BENZENE; CATECHOL DERIVATIVE; LUCIFERASE; PHENOL DERIVATIVE; PROTEIN C MYB; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHICKEN; DOSE RESPONSE; ENZYME ACTIVITY; ERYTHROBLAST; METABOLITE; NONHUMAN; ONCOGENE C MYB; PROTEIN PHOSPHORYLATION;

ANIMALS; BENZENE; CATECHOLS; CELL LINE; CHICKENS; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROBLASTS; GENES, MYB; IMMUNOBLOTTING; LUCIFERASES; PHENOL; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; SIGNAL TRANSDUCTION; TRANSFECTION;

GALLUS GALLUS;

EID: 8444221939     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.05.010     Document Type: Article

References (42)

1. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene. 18:1999;6104-6111
2. Amson R., Sigaux F., Przedborski S., Flandrin G., Givol D., Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8857-8861
3. Beug H., Doederlein G., Freudenstein C., Graf T. Erythroblast cell lines transformed by a temperature-sensitive mutant of avian erythroblastosis virus: a model system to study erythroid differentiation in vitro. J. Cell. Physiol. (Suppl. 1):1982;195-207
4. Chapman D.E., Namkung M.J., Juchau M.R. Benzene and benzene metabolites as embryotoxic agents: effects on cultured rat embryos. Toxicol. Appl. Pharmacol. 128:1994;129-137
5. Corti M., Snyder C.A. Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol. Sci. 41:1998;42-48
6. Cronkite E.P., Bullis J., Inoue T., Drew R.T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 75:1984;358-361
7. Dash A.B., Orrico F.C., Ness S.A. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev. 10:1996;1858-1869
8. Duarte-Davidson R., Courage C., Rushton L., Levy L. Benzene in the environment: an assessment of the potential risks to the health of the population. Occup. Environ. Med. 58:2001;2-13
9. Dubendorff J.W., Lipsick J.S. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site. Oncogene. 18:1999;3452-3460
10. Dyer B.W., Fernando A.F., Klinedinst D.K., Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem. 282:2000;158-161
11. Fabiani R., De B.A., Rosignoli P., Scamosci M., Lepore L., Morozzi G. Influence of culture conditions on the DNA-damaging effect of benzene and its metabolites in human peripheral blood mononuclear cells. Environ. Mol. Mutat. 37:2001;1-6
12. Farris G.M., Wong V.A., Wong B.A., Janszen D.B., Shah R.S. Benzene-induced micronuclei in erythrocytes: an inhalation concentration- response study in B6C3F1 mice. Mutagenesis. 11:1996;455-462
13. Ferrao P., Macmillan E.M., Ashman L.K., Gonda T.J. Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene. 11:1995;1631-1638
14. Gewirtz A.M. Myb targeted therapeutics for the treatment of human malignancies. Oncogene. 18:1999;3056-3062
15. Grdisa M., White M.K. Molecular and biochemical events during differentiation of the HD3 chicken erythroblastic cell line. Int. J. Biochem. Cell Biol. 35:2003;422-431
16. Hayes R.B., Yin S., Rothman N., Dosemeci M., Li G., Travis L.T., Smith M.T., Linet M.S. Benzene and lymphohematopoietic malignancies in China. J. Toxicol. Environ. Health, Part A. 61:2000;419-432
17. Ho T.Y., Witz G. Increased gene expression in human promyeloid leukemia cells exposed to trans,trans-muconaldehyde, a hematotoxic benzene metabolite. Carcinogenesis. 18:1997;739-744
18. Kolachana P., Subrahmanyam V.V., Meyer K.B., Zhang L., Smith M.T. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vitro. Cancer Res. 53:1993;1023-1026
19. Leverson J.D., Koskinen P.J., Orrico F.C., Rainio E.M., Jalkanen K.J., Dash A.B., Eisenman R.N., Ness S.A. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell. 2:1998;417-425
20. Lewis J.G., Stewart W., Adams D.O. Role of oxygen radicals in induction of DNA damage by metabolites of benzene. Cancer Res. 48:1988;4762-4765
21. 14C]benzene in rodents, using accelerator mass spectrometry. Toxicol. Appl. Pharmacol. 159:1999;83-90
22. Moran J.L., Siegel D., Sun X.M., Ross D. Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells. Mol. Pharmacol. 50:1996;610-615
23. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., Pietryga D.W., Scott W.J.J., Potter S.S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:1991;677-689
24. Ness S.A. Myb binding proteins: regulators and cohorts in transformation. Oncogene. 18:1999;3039-3046
25. Ness S.A., Marknell A., Graf T. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell. 59:1989;1115-1125
26. Neun D.J., Penn A., Snyder C.A. Evidence for strain-specific differences in benzene toxicity as a function of host target cell susceptibility. Arch. Toxicol. 66:1992;11-17
27. Ning H., Kado N.Y., Kuzmicky P.A., Hsieh D.P. Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells. Environ. Mol. Mutat. 18:1991;1-5
28. Oh I.H., Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene. 18:1999;3017-3033
29. Oshiro Y., Balwierz P.S., Witz G. Micronucleus formation in mouse bone marrow cells in vivo in response to trans,trans-muconaldehyde. Toxicol. Lett. 121:2001;159-166
30. Pircher T.J., Zhao S., Geiger J.N., Joneja B., Wojchowski D.M. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene. 19:2000;3684-3692
31. Powley M.W., Carlson G.P. Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice. Toxicology. 169:2001;187-194
32. Rithidech K., Au W.W., Ramanujam V.M., Whorton E.B., Legator M.S. Induction of chromosome aberrations in lymphocytes of mice after subchronic exposure to benzene. Mutat. Res. 188:1987;135-140
33. Seidel H.J., Barthel E., Schafer F., Schad H., Weber L. Action of benzene metabolites on murine hematopoietic colony-forming cells in vitro. Toxicol. Appl. Pharmacol. 111:1991;128-131
34. Shen Y., Shen H.M., Shi C.Y., Ong C.N. Benzene metabolites enhance reactive oxygen species generation in HL60 human leukemia cells. Hum. Exp. Toxicol. 15:1996;422-427
35. Storer R.D., Cartwright M.E., Cook W.O., Soper K.A., Nichols W.W. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice. Carcinogenesis. 16:1995;285-293
36. Tsutsui T., Hayashi N., Maizumi H., Huff J., Barrett J.C. Benzene, catechol, hydroquinone and phenol induced cell transformation, gene mutations, chromosome aberrations, aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutat. Res. 373:1997;113-123
37. Valentine J.L., Lee S.S.T., Seaton M.J., Asgharian B., Farris G., Corton J.C., Gonzalez F.J., Medinsky M.A. Reduction of Benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141:1996;205-213
38. Winn L.M., Lei W., Ness S.A. Pim-1 phosphorylates the DNA binding domain of c-Myb. Cell Cycle. 2:2003;258-262
39. Wolff L., Schmidt M., Koller R., Haviernik P., Watson R., Bies J., Maciag K. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells. Blood Cells Mol. Dis. 27:2001;483-488
40. Wong O. Risk of acute myeloid leukemia and multiple myeloma in workers exposed to benzene. Occup. Environ. Med. 52:1995;380-384
41. Yardley-Jones A., Anderson D., Parke D.V. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br. J. Ind. Med. 48:1991;437-444
42. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kim D.Y., Inoue T. Mechanism of action of benzene toxicity: cell cycle supression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol. 29:2001;278-285